| Product Code: ETC339621 | Publication Date: Aug 2022 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The China Placenta Market was estimated at USD 170 Million in 2025 and is projected to reach USD 195 Million by 2032, growing at a CAGR of 2.0% from 2026 to 2032. This growth trajectory is largely propelled by a surge in consumer awareness regarding the benefits of placenta-derived products, particularly in skincare and wellness. Increasing disposable incomes and a cultural shift towards natural health solutions further bolster the demand for these products across various sectors.
This graph highlights how the China Placenta Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -4.0% | decrease in consumer interest |
| 2022 | 6.2% | rising health awareness trend |
| 2023 | -2.1% | drop in market investments |
| 2024 | 3.8% | expansion of wellness industry |
| 2025 | 3.0% | growth in beauty applications |
| 2026 | 3.9% | increased scientific research funding |
| 2027 | 2.7% | surge in holistic therapies |
| 2028 | 2.5% | enhanced product availability online |
| 2029 | 3.3% | growing demand for natural products |
| 2030 | 2.7% | wider acceptance in skincare |
| 2031 | 3.1% | growing automotive sector requirements |
| 2032 | 2.7% | increased collaboration among brands |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
The strongest force shaping the China Placenta Market right now is the escalating consumer demand for natural and effective health solutions. As awareness of the purported anti-aging, skin rejuvenation, and immune-boosting properties of placenta extracts grows, consumers are increasingly gravitating toward these products in cosmetics and dietary supplements.
Additionally, the evolving lifestyle patterns characterized by heightened health consciousness play a crucial role in the market's expansion. Companies are responding with innovative formulations that cater to the rising preferences for premium, placenta-based skincare and health products, establishing a burgeoning industry dynamic.
Despite its promising growth, the China Placenta Market faces significant restraints primarily stemming from regulatory hurdles and ethical concerns. The stringent regulations surrounding the production and distribution of placenta-based products necessitate comprehensive navigation through complex approval processes. This can often deter potential entrants or innovations in the space. Moreover, cultural taboos regarding the consumption of placenta may hinder widespread market acceptance, necessitating concerted marketing and educational efforts to address consumer hesitance.
Current trends indicate a marked increase in consumer preference for high-quality, natural ingredients in health and beauty products. The integration of placenta extracts into advanced skincare formulations, touted for their anti-aging properties, is becoming a focal point for brands aiming to differentiate in a competitive market. Moreover, rising interest in holistic wellness is driving growth in placenta-based dietary supplements, with consumers seeking natural alternatives to conventional pharmaceuticals.
The China Placenta Market offers a myriad of investment opportunities as demand escalates for placenta-based innovations. Companies that specialize in placenta extraction and processing stand to benefit significantly, especially those committed to research and development. Exploring new applications for placenta extracts, particularly in areas like regenerative medicine, presents a lucrative avenue for investors looking to capitalize on emerging market trends and consumer preferences.
The Chinese government has instituted robust regulations overseeing the use of placenta products, treating them as biological entities subject to strict guidelines by the National Medical Products Administration (NMPA). This regulatory framework aims to ensure the safety and efficacy of these products while curbing illegal practices. Furthermore, public spending is increasingly being directed toward research initiatives focused on the therapeutic potential of placenta-derived substances, reflecting a governmental commitment to harnessing these natural resources within an ethical and compliant framework.
Looking ahead to 2026-2032, the China Placenta Market is set to experience notable growth. The increasing popularity of anti-aging and wellness products will likely drive demand, supported by rising disposable incomes and an overarching trend towards natural ingredients. While regulatory challenges persist, technological advancements in extraction processes and a focus on ethical sourcing will play critical roles in shaping market dynamics and opening new avenues for product development.
In recent months, the China Placenta Market has seen a surge in product innovation, with companies launching new placenta-infused skincare lines aimed at premium segments. Additionally, there has been an uptick in collaborative research efforts between academia and industry players focused on developing advanced placenta extraction techniques. These initiatives not only emphasize quality and compliance but also reflect a growing commitment to sustainability in the sourcing and processing of placenta-derived products.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Placenta Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Placenta Market Revenues & Volume, 2022 & 2032F |
3.3 China Placenta Market - Industry Life Cycle |
3.4 China Placenta Market - Porter's Five Forces |
3.5 China Placenta Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 China Placenta Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 China Placenta Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of placenta products for skincare and health in China |
4.2.2 Growing disposable income leading to higher spending on premium healthcare and beauty products |
4.2.3 Rising demand for natural and organic ingredients in beauty and wellness products in China |
4.3 Market Restraints |
4.3.1 Stringent regulations and ethical concerns related to the sourcing and use of placenta in products |
4.3.2 Cultural taboos and stigma associated with the use of placenta-based products in China |
5 China Placenta Market Trends |
6 China Placenta Market, By Types |
6.1 China Placenta Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Placenta Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 China Placenta Market Revenues & Volume, By Porcine, 2022-2032F |
6.1.4 China Placenta Market Revenues & Volume, By Equine, 2022-2032F |
6.1.5 China Placenta Market Revenues & Volume, By Ovine, 2022-2032F |
6.1.6 China Placenta Market Revenues & Volume, By Others, 2022-2032F |
6.2 China Placenta Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Placenta Market Revenues & Volume, By Pharmaceuticals, 2022-2032F |
6.2.3 China Placenta Market Revenues & Volume, By Cosmetics, 2022-2032F |
6.2.4 China Placenta Market Revenues & Volume, By Supplements, 2022-2032F |
6.2.5 China Placenta Market Revenues & Volume, By Others, 2022-2032F |
7 China Placenta Market Import-Export Trade Statistics |
7.1 China Placenta Market Export to Major Countries |
7.2 China Placenta Market Imports from Major Countries |
8 China Placenta Market Key Performance Indicators |
8.1 Number of new product launches containing placenta extracts or derivatives in the Chinese market |
8.2 Growth in the number of beauty and wellness clinics offering placenta-based treatments in China |
8.3 Increase in online searches and social media mentions related to placenta products in China |
9 China Placenta Market - Opportunity Assessment |
9.1 China Placenta Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 China Placenta Market Opportunity Assessment, By Application, 2022 & 2032F |
10 China Placenta Market - Competitive Landscape |
10.1 China Placenta Market Revenue Share, By Companies, 2025 |
10.2 China Placenta Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here